Risk of Fetal Anomalies With Exposure to Selective Serotonin Reuptake Inhibitors

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 1998-06, Vol.279 (23), p.1873-1873
Main Author: Grush, Lynn R
Format: Article
Language:English
Subjects:
1-Naphthylamine - adverse effects
1-Naphthylamine - analogs & derivatives
Antidepressive Agents - adverse effects
Female
Fluvoxamine - adverse effects
Humans
Paroxetine - adverse effects
Pregnancy
Pregnancy Outcome
Risk
Serotonin Uptake Inhibitors - adverse effects
Sertraline
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1873
container_issue 23
container_start_page 1873
container_title JAMA : the journal of the American Medical Association
container_volume 279
creator Grush, Lynn R
description
doi_str_mv 10.1001/jama.279.23.1873
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_211367227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>1152183</ama_id><sourcerecordid>800335541</sourcerecordid><originalsourceid>FETCH-LOGICAL-a329t-3a63fea3524b29188aff9647b1bd22e70f781adf4c9f9347d0aed1b4665da4a43</originalsourceid><addsrcrecordid>eNqFkF1LwzAUhoMoc07vRRCC9635apNcjrHpYKBMxcuSrgnL1jY1SUX_vYUNL_XcvAeeh3PgBeAaoxQjhO93qlEp4TIlNMWC0xMwxhkVCc2kOAVjhKRIOBPsHFyEsEPDYMpHYCRzykhGxuB5bcMeOgMXOqoaTlvXqNrqAN9t3ML5V-dC7zWMDr7oWm-i_dTD5l10rW3hWvddVHsNl-3WljY6Hy7BmVF10FfHnIC3xfx19pisnh6Ws-kqUZTImFCVU6MVzQgricRCKGNkzniJy4oQzZHhAqvKsI00kjJeIaUrXLI8zyrFFKMTcHe423n30esQi53rfTu8LAjGNOeE8H8kIjPGxSDdHqW-bHRVdN42yn8Xx44GfnPgQ9e_EOOMYMH-gpT-AJiYeOo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211295478</pqid></control><display><type>article</type><title>Risk of Fetal Anomalies With Exposure to Selective Serotonin Reuptake Inhibitors</title><source>JAMA Network</source><creator>Grush, Lynn R</creator><creatorcontrib>Grush, Lynn R</creatorcontrib><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.279.23.1873</identifier><identifier>PMID: 9634252</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>1-Naphthylamine - adverse effects ; 1-Naphthylamine - analogs &amp; derivatives ; Antidepressive Agents - adverse effects ; Female ; Fluvoxamine - adverse effects ; Humans ; Paroxetine - adverse effects ; Pregnancy ; Pregnancy Outcome ; Risk ; Serotonin Uptake Inhibitors - adverse effects ; Sertraline</subject><ispartof>JAMA : the journal of the American Medical Association, 1998-06, Vol.279 (23), p.1873-1873</ispartof><rights>Copyright National Library of Medicine - MEDLINE Abstracts Jun 17 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9634252$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grush, Lynn R</creatorcontrib><title>Risk of Fetal Anomalies With Exposure to Selective Serotonin Reuptake Inhibitors</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><subject>1-Naphthylamine - adverse effects</subject><subject>1-Naphthylamine - analogs &amp; derivatives</subject><subject>Antidepressive Agents - adverse effects</subject><subject>Female</subject><subject>Fluvoxamine - adverse effects</subject><subject>Humans</subject><subject>Paroxetine - adverse effects</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>Risk</subject><subject>Serotonin Uptake Inhibitors - adverse effects</subject><subject>Sertraline</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkF1LwzAUhoMoc07vRRCC9635apNcjrHpYKBMxcuSrgnL1jY1SUX_vYUNL_XcvAeeh3PgBeAaoxQjhO93qlEp4TIlNMWC0xMwxhkVCc2kOAVjhKRIOBPsHFyEsEPDYMpHYCRzykhGxuB5bcMeOgMXOqoaTlvXqNrqAN9t3ML5V-dC7zWMDr7oWm-i_dTD5l10rW3hWvddVHsNl-3WljY6Hy7BmVF10FfHnIC3xfx19pisnh6Ws-kqUZTImFCVU6MVzQgricRCKGNkzniJy4oQzZHhAqvKsI00kjJeIaUrXLI8zyrFFKMTcHe423n30esQi53rfTu8LAjGNOeE8H8kIjPGxSDdHqW-bHRVdN42yn8Xx44GfnPgQ9e_EOOMYMH-gpT-AJiYeOo</recordid><startdate>19980617</startdate><enddate>19980617</enddate><creator>Grush, Lynn R</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>19980617</creationdate><title>Risk of Fetal Anomalies With Exposure to Selective Serotonin Reuptake Inhibitors</title><author>Grush, Lynn R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a329t-3a63fea3524b29188aff9647b1bd22e70f781adf4c9f9347d0aed1b4665da4a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>1-Naphthylamine - adverse effects</topic><topic>1-Naphthylamine - analogs &amp; derivatives</topic><topic>Antidepressive Agents - adverse effects</topic><topic>Female</topic><topic>Fluvoxamine - adverse effects</topic><topic>Humans</topic><topic>Paroxetine - adverse effects</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>Risk</topic><topic>Serotonin Uptake Inhibitors - adverse effects</topic><topic>Sertraline</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grush, Lynn R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grush, Lynn R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of Fetal Anomalies With Exposure to Selective Serotonin Reuptake Inhibitors</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>1998-06-17</date><risdate>1998</risdate><volume>279</volume><issue>23</issue><spage>1873</spage><epage>1873</epage><pages>1873-1873</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><cop>United States</cop><pub>American Medical Association</pub><pmid>9634252</pmid><doi>10.1001/jama.279.23.1873</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 1998-06, Vol.279 (23), p.1873-1873
issn 0098-7484
1538-3598
language eng
recordid cdi_proquest_journals_211367227
source JAMA Network
subjects 1-Naphthylamine - adverse effects
1-Naphthylamine - analogs & derivatives
Antidepressive Agents - adverse effects
Female
Fluvoxamine - adverse effects
Humans
Paroxetine - adverse effects
Pregnancy
Pregnancy Outcome
Risk
Serotonin Uptake Inhibitors - adverse effects
Sertraline
title Risk of Fetal Anomalies With Exposure to Selective Serotonin Reuptake Inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T07%3A10%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20Fetal%20Anomalies%20With%20Exposure%20to%20Selective%20Serotonin%20Reuptake%20Inhibitors&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Grush,%20Lynn%20R&rft.date=1998-06-17&rft.volume=279&rft.issue=23&rft.spage=1873&rft.epage=1873&rft.pages=1873-1873&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.279.23.1873&rft_dat=%3Cproquest_pubme%3E800335541%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a329t-3a63fea3524b29188aff9647b1bd22e70f781adf4c9f9347d0aed1b4665da4a43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=211295478&rft_id=info:pmid/9634252&rfr_iscdi=true